Q: Notwithstanding the weaker than expected sales growth of their 2 products, is there any merit to buying TH at current prices, especially as they might be entering the NASH/NAFLD market. Balance sheet looks ok for now. Thanks
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Please comment on today's update of revenues. Thanks
Q: This question is related to my question submitted yesterday on tax loss selling.
I was aware of the article in the blog section related to this topic and had already read it. The information I was looking for was which, of this long list of companies, do you consider the best options to purchase during the season.
Also, I did not intend that initial question to be private; I do not believe I marked it in this way, and I am fine with you posting the answer publically.
Thanks in advance.
DON
I was aware of the article in the blog section related to this topic and had already read it. The information I was looking for was which, of this long list of companies, do you consider the best options to purchase during the season.
Also, I did not intend that initial question to be private; I do not believe I marked it in this way, and I am fine with you posting the answer publically.
Thanks in advance.
DON
-
Sangoma Technologies Corporation (STC)
-
Theratechnologies Inc. (TH)
-
Blackline Safety Corp. (BLN)
-
Namsys Inc. (CTZ)
-
Viemed Healthcare Inc. (VMD)
-
Martello Technologies Group Inc. (MTLO)
Q: I'm looking to add one or more of these high growth, high risk stocks to my portfolio. How would you rank these companies?
Q: TH reported yesterday. What do you think of earnings report ? Sales up 62 % and they have applied for listing on NASDAQ. Stock fell on announcement . Should I buy TH.? Bob
Q: What is your current thinking on this company for a 1-2 year hold? What do you consider a good entry point if a possible investment?
Thank you
Thank you
Q: notwithstanding what seems to be a good AGM yesterday and with further announcements forthcoming, the stock is mired at it new low for the year with much selling to offset any new buying. Good balance sheet with improving fundamentals. What gives here?? Some manipulation to keep it depressed?
Q: If I sold my GUD, but wish to stay in junior pharma, could you recommend 2 or 3 good alternatives. Thank you, Gaston
Q: please comment on today's quarterly report. thanks
Q: Any idea why TH has been so weak lately. I know sales have been short of expectations for their new life saving drug but they are still rising slowly. Also their older drug Egrifta may have some benefits for people with NAFLD/NASH. Balance sheet is good.
Should one buy here?
Should one buy here?
Q: Theratechnologies was at $9.35 on Feb 28th and it closed on Mar 15th at $6.99. The recent press releases all seem favorable to me. Why is this stock down so dramatically?
Q: Over the past 5 days TH shares are up 10 %. Now at $ 7.70. This is a good move in such a Down Market. Should I buy at this level. Any idea why it has held up so well ? RAK.
Q: Is there any reason TH continues to drop in view of their seemingly excellent 3Q report, released Oct 4. First time EBITDA positive with good growth ahead, good balance sheet with 66 mil in cash and really no debt. An enigma!! thanks
Q: Would appreciate your comments on TH after 3Q results today. They seem to be doing well and the outlook seems very favourable. thanks
Q: TH $ 9.60 is showing some strength on back of a good quarter. What is their drug Trogarzo ?
Outlook is promising don't you think ? RAK
Outlook is promising don't you think ? RAK
Q: With the patent protection now extended for drugs for two years longer, do you have any suggestions as to co's in that space that might benefit?
Q: I’m tired of owning Knight theraputics and it’s potential whatever.....it’s been two years ......can you recommend something different
Q: I have set 8% sector target and have invested 50% - GUD 15% of total target, TD Health Sciences 11%, and 9% each to ISRG, ILMN, and COV.
If I drop TD Fund, then 60% available to reinvest - what names and allocations do you advise?
Thx for your excellent advice,
Sam
If I drop TD Fund, then 60% available to reinvest - what names and allocations do you advise?
Thx for your excellent advice,
Sam
Q: Thinking of adding one or both to my TFSA. Any reasons or concerns I should be aware of?
Q: Thoughts on the RBC analyst posting an $11 target? Quite a drop on that. Would you buy on this dip? What price target would you put on the stock in a buyout scenario by a larger company? Is this likely?